Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis
…, R Gibe, A Moreau, MM Morshed, RN Young
Index: Arns, Steve; Gibe, Romelo; Moreau, Anne; Monzur Morshed; Young, Robert N. Bioorganic and Medicinal Chemistry, 2012 , vol. 20, # 6 p. 2131 - 2140
Full Text: HTML
Citation Number: 18
Abstract
There is an important medical need for effective therapies to redress the general bone loss associated with advanced osteoporosis. Prostaglandin E2 and related EP4 receptor agonists have been shown to stimulate bone regrowth but their use has been limited by systemic side effects. Herein is described the design and synthesis of novel dual-action bone-targeting conjugate pro-drugs where two classes of active agents, a bone growth ...
Related Articles:
[Larksarp, Chitchamai; Alper, Howard Journal of Organic Chemistry, 1999 , vol. 64, # 25 p. 9194 - 9200]
[Kowalski, Piotr; Jaskowska, Jolanta; Bojarski, Andrzej J.; Duszynska, Beata Journal of Heterocyclic Chemistry, 2008 , vol. 45, # 1 p. 209 - 214]
[Zhu, Xiaoxiang; Yu, Qian-sheng; Greig, Nigel H.; Flippen-Anderson, Judith L.; Brossi, Arnold Heterocycles, 2003 , vol. 59, # 1 p. 115 - 128]
[Zhu, Xiaoxiang; Yu, Qian-sheng; Greig, Nigel H.; Flippen-Anderson, Judith L.; Brossi, Arnold Heterocycles, 2003 , vol. 59, # 1 p. 115 - 128]